First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 14, 2024

Meridian Bioscience Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Operating Expenses Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Operating Expenses
-$112.8m
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Operating Expenses
-$1.9B
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Operating Expenses
-$1.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
Align Technology Inc
NASDAQ:ALGN
Operating Expenses
-$2.1B
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-20%
Lantheus Holdings Inc
NASDAQ:LNTH
Operating Expenses
-$399.9m
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-17%

See Also

What is Meridian Bioscience Inc's Operating Expenses?
Operating Expenses
-112.8m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Operating Expenses amounts to -112.8m USD.

What is Meridian Bioscience Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-7%

Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for Meridian Bioscience Inc have been -12% over the past three years , -7% over the past five years .